Brief: Mustang Bio Reports Second Quarter 2022 Financial Results And Recent Corporate Highlights
11/08/2022 21:39
Aug 11 (Reuters) - Mustang Bio Inc MBIO.O :
* MUSTANG BIO REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
AND
RECENT CORPORATE HIGHLIGHTS
* Q2 LOSS PER SHARE $0.19
Source text for Eikon: ID:nGNX4GHKxn
Further company coverage: MBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mustang Bio
See all newsAdvisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
U.S. STOCKS ON THE MOVE-Dow, Phibro, Mustang Bio
Mustang soars on FDA's orphan drug tag for brain cancer therapy
Mustang Bio Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Mustang Bio Inc - Enters Sale And Surrender Agreement With Abbvie